OKUR

Conviction 67HealthcareScan · Mon, Aug 10, 2026

OKUR$4.07-1.81%

ResistanceSupportVol 14

Vol MA14 276.63K

May 11May 28Jun 16Jul 6Jul 23Aug 10

OnKure Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.onkuretherapeutics.com ↗

Price4.07

Change-1.81%

Gap-3.14%

Rel volume17.12×

Avg volume222.23K

Avg $ vol907.03K

SMA 204.10

SMA 504.24

SMA 2003.60

Price vs 50-4.13%

Price vs 200+12.95%

MA stackmixed

50/200 cross—

Supertrendup · 3.60

RSI (14)47

MACD hist0.01

MACD crossbull · 2d

Stoch %K / %D45 / 52

ADX (14)15

+DI / −DI15 / 18

RSI divergence—

MACD divergenceBullish

ATR %+7.96%

ADR %7.69%

52w high5.27

52w low2.00

From 52w high-22.87%

Above 52w low+103.25%

New 52w highNo

SqueezeOn · 37d

Bollinger width11.02%

%B0.41

Donchian pos43.87%

Donchian high4.51

Donchian low3.72

AVWAP (52w high)4.22

vs AVWAP high-3.71%

AVWAP (52w low)3.75

vs AVWAP low+8.47%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d17.12×

Avg vol (14d)276.63K

Avg vol (20d)222.23K

Avg $ vol (20d)907.03K

Market cap164.62M

RS 3m (vs SPY)-1.15%

RS 6m (vs SPY)+64.33%

RS line new highNo

Trend template6/8

Technical rank60.5

1 week+1.12%

1 month-5.02%

3 months+3.96%

6 months+62.60%

1 year+102.24%

YTD+37.33%

P/E-2.77

P/B0.96

P/S—

P/FCF-3.17

EPS-4.40

Div yield—

ROE-34.58%

ROA-33.18%

Debt/Eq—

Current26.75

EV/EBITDA0.03

Gross margin—

Net margin—

Rev growth—

EPS growth-12.99%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.88M

Revenue—

Net income-15.35M

Gross profit—

Free cash flow-51.87M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out40.4M

Employees45

ListedMon, Oct 7, 2024

Free float9.81M

Float %71.8%

Short interest1.18M

Days to cover5.8d

Short volume35.3%

Squeeze score64 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank60.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.67

Support3.73

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OKUR

All disclosures →

No recent disclosed trades by Congress in OKUR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OKUR · 6 buys

Insider	Side	Shares	Value	Traded	Filed
GREY MICHAEL G Director · Stock Option (right to buy) · 2026-06-04	Grant	7.65K	$0	2026-06-04	2026-06-08
Ratcliffe Liam Director · Stock Option (right to buy) · 2026-06-04	Grant	1.27K	$0	2026-06-04	2026-06-08
Phillips Andrew John Director · Stock Option (right to buy) · 2026-06-04	Grant	7.65K	$0	2026-06-04	2026-06-08
Mathers Edward T Director · Stock Option (right to buy) · 2026-06-04	Grant	7.65K	$0	2026-06-04	2026-06-08
Jansen Valerie Malyvanh Director · Stock Option (right to buy) · 2026-06-04	Grant	7.65K	$0	2026-06-04	2026-06-08
Carruthers R Michael Director · Stock Option (right to buy) · 2026-06-04	Grant	7.65K	$0	2026-06-04	2026-06-08

SEC filings

EDGAR filings in OKUR · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.